Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth I Maynard

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Journal of Neuroscience Research|July 12, 2002
Acute administration of Ginkgo biloba extract (EGb 761) affords neuroprotection against permanent and transient focal cerebral ischemia in Sprague-Dawley ratsE-Jian Lee, Hung-Yi Chen, Tian-Shung Wu, et al.
Drug Safety|May 16, 2021
Enhancing Pharmacovigilance from the US Experience: Current Practices and Future OpportunitiesVeronique F Kugener, Eric S Freedland, Kenneth I Maynard, et al.
AJNR. American Journal of Neuroradiology|June 14, 2002
Functional CT perfusion imaging in predicting the extent of cerebral infarction from a 3-hour middle cerebral arterial occlusion in a primate stroke modelLeena M Hamberg, George J Hunter, Kenneth I Maynard, et al.
Current Neurovascular Research|August 22, 2006
Delayed treatment with nicotinamide inhibits brain energy depletion, improves cerebral microperfusion, reduces brain infarct volume, but does not alter neurobehavioral outcome following permanent focal cerebral ischemia in Sprague Dawley ratsE-Jian Lee, Tian-Shung Wu, Guan-Liang Chang, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|October 2, 2007
Acute studies of a new primate model of reversible middle cerebral artery occlusionAlex J de Crespigny, Helen E D'Arceuil, Kenneth I Maynard, et al.
Toxicology and Applied Pharmacology|April 27, 2007
Biological stress response terminology: Integrating the concepts of adaptive response and preconditioning stress within a hormetic dose-response frameworkEdward J Calabrese, Kenneth A Bachmann, A John Bailer, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal of Neuroscience Research|July 12, 2002
Acute administration of Ginkgo biloba extract (EGb 761) affords neuroprotection against permanent and transient focal cerebral ischemia in Sprague-Dawley ratsE-Jian Lee, Hung-Yi Chen, Tian-Shung Wu, et al.
Drug Safety|May 16, 2021
Enhancing Pharmacovigilance from the US Experience: Current Practices and Future OpportunitiesVeronique F Kugener, Eric S Freedland, Kenneth I Maynard, et al.
AJNR. American Journal of Neuroradiology|June 14, 2002
Functional CT perfusion imaging in predicting the extent of cerebral infarction from a 3-hour middle cerebral arterial occlusion in a primate stroke modelLeena M Hamberg, George J Hunter, Kenneth I Maynard, et al.
Current Neurovascular Research|August 22, 2006
Delayed treatment with nicotinamide inhibits brain energy depletion, improves cerebral microperfusion, reduces brain infarct volume, but does not alter neurobehavioral outcome following permanent focal cerebral ischemia in Sprague Dawley ratsE-Jian Lee, Tian-Shung Wu, Guan-Liang Chang, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|October 2, 2007
Acute studies of a new primate model of reversible middle cerebral artery occlusionAlex J de Crespigny, Helen E D'Arceuil, Kenneth I Maynard, et al.
Toxicology and Applied Pharmacology|April 27, 2007
Biological stress response terminology: Integrating the concepts of adaptive response and preconditioning stress within a hormetic dose-response frameworkEdward J Calabrese, Kenneth A Bachmann, A John Bailer, et al.
Pageof 2